UNCY - Unicycive Therapeutics GAAP EPS of -$0.37 misses by $0.09 revenue of $0.95M November, 14 2022 09:12 AM Unicycive Therapeutics Inc. Unicycive Therapeutics press release ( NASDAQ: UNCY ): Q3 GAAP EPS of -$0.37 misses by $0.09 . Revenue of $0.95M. For further details see: Unicycive Therapeutics GAAP EPS of -$0.37 misses by $0.09, revenue of $0.95M